Corium is a commercial-stage biopharmaceutical company that is leading the development and commercialization of central nervous system (CNS) healthcare therapies that provide clinicians with important treatment options for patients, their families, and their caregivers.

Collaborating with some of the world's largest pharmaceutical and consumer product companies, we have a track record and depth of experience in taking products from concept, through development, to manufacturing and final commercialization. 

Biotechnology

Medical Devices

Therapeutics

Corium

Mark Sirgo

Matthew Hand

Shay Etler

Jill Cafaro

Brittany Rivard

Magdalena C.

Denise Kim-O'Neill

Blythe Buchanan (she/her)

Tanya Bloker

Josephine Pedalino

Kevin Ostrander

John Neeley

Jeffrey Gaffey

Gary Cleary

Yi Xu

Charles Oh

The Leadership Team at Corium is responsible for setting the strategic direction of the company, driving the development and commercialization of CNS healthcare therapies. Comprised of top executives, the team ensures robust regulatory compliance, spearheads market access and commercial strategies, oversees financial planning and analysis, and fosters key partnerships to advance the company’s mission and objectives.

Leadership Team

Marketing and Market Access

Medical and Regulatory Affairs

Leadership Team

About

Team members

Other teams at Corium

Marketing and Market Access

Medical and Regulatory Affairs